Micro Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MICRO LABS, and what generic and branded alternatives to MICRO LABS drugs are available?
MICRO LABS has eighty-three approved drugs.
There are nine tentative approvals on MICRO LABS drugs.
Summary for Micro Labs
US Patents: | 0 |
Tradenames: | 74 |
Ingredients: | 74 |
NDAs: | 83 |
Patent Litigation for Micro Labs: | See patent lawsuits for Micro Labs |
PTAB Cases with Micro Labs as petitioner: | See PTAB cases with Micro Labs as petitioner |
Drugs and US Patents for Micro Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Micro Labs | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 212172-001 | Aug 1, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Micro Labs | AMLODIPINE AND OLMESARTAN MEDOXOMIL | amlodipine besylate; olmesartan medoxomil | TABLET;ORAL | 207435-002 | Nov 2, 2017 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Micro Labs | LEVOCETIRIZINE DIHYDROCHLORIDE | levocetirizine dihydrochloride | TABLET;ORAL | 211551-001 | Nov 20, 2018 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Micro Labs | FORMOTEROL FUMARATE | formoterol fumarate | SOLUTION;INHALATION | 218304-001 | Jun 26, 2024 | AN | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Micro Labs | DALFAMPRIDINE | dalfampridine | TABLET, EXTENDED RELEASE;ORAL | 210158-001 | Mar 11, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.